purpose study developed evaluate use combined photons protons treatment locally advanced carcinoma prostate report preliminary assessment morbidity tumor response methods materials patients stages t2b b2 t2c b2 t3 c treated NUMBER gy irradiation pelvis additional NUMBER cobalt gray equivalent cge prostate protons yielding total prostate dose NUMBER cge NUMBER fractions median time NUMBER months range months toxicity scored according radiation therapy oncology group rtog grading local control evaluated serial digital rectal examination dre prostate specific antigen psa measurements results morbidity evaluation available NUMBER patients actuarial rate grade NUMBER NUMBER late morbidity NUMBER NUMBER rectal NUMBER urinary patients demonstrated grade NUMBER NUMBER late morbidity treatment response evaluated NUMBER patients elevated pretreatment serum psa levels actuarial rate psa normalization NUMBER NUMBER NUMBER pretreatment psas NUMBER respectively NUMBER patients rising psa demonstrated local recurrence NUMBER patients distant metastasis NUMBER patients evidence disease increasing psa NUMBER patients conclusions low incidence effects despite tumor dose NUMBER cge demonstrates conformal protons deliver higher doses radiation target tissues increasing complications surrounding normal tissues initial tumor response assessed high actuarial rate normalization pretreatment psa NUMBER low rate recurrences treatment field NUMBER encouraging treatment related photon beam NUMBER mev follow NUMBER NUMBER NUMBER year NUMBER year NUMBER NUMBER NUMBER NUMBER